E. Kukučková

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome

V. Krčméry, E. Oravcová, S. Špánik et al. · Journal of Antimicrobial Chemotherapy · 1998 · 101 citations · Full text

Pathology, Clinical Mycology, Antimicrobial Chemotherapy +19

Do Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?

K. Kralovicová, S. Špánik, J. Halko et al. · Journal of Chemotherapy · 1997 · 39 citations

Invasive mold infections in cancer patients: 5 years' experience withAspergillus, Mucor, Fusarium andAcremonium infections

V. Krčméry, E. Kunova, Zdenka Jesenská et al. · Supportive Care in Cancer · 1996 · 33 citations

Mold Control, Antifungal Agent, Invasive Mold Infections +7

<i>Candida</i><i>glabrata</i>, <i>Candida</i><i>krusei</i>, Non-albicans <i>Candida</i> spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of Fluconazole

A. Kunová, J. Trupl, S. Špánik et al. · Chemotherapy · 1995 · 28 citations

Diagnostic Mycology, Pathogenic Microbiology, Pathology +17

Funguria in cancer patients: Analysis of risk factors, clinical presentation and outcome in 50 patients

E. Oravcová, M. Studená, E. Kukučková et al. · Infection · 1996 · 23 citations

Urology, Surgical Oncology, Cancer Risk +8